Nurix Therapeutics Announces $250.0 Million Registered Offering of Common Stock
Globenewswire· 2025-10-22 11:20
Core Viewpoint - Nurix Therapeutics, Inc. has announced the pricing of its underwritten registered offering of 24,485,799 shares at $10.21 per share, aiming to raise approximately $250 million for clinical development and research activities [1][4]. Group 1: Offering Details - The offering consists of 24,485,799 shares priced at $10.21 each, with expected gross proceeds of $250 million before expenses [1]. - The offering is set to close on or about October 23, 2025, pending customary closing conditions [1]. - Participation in the offering includes both new and existing investors such as General Atlantic and Redmile Group [2]. Group 2: Use of Proceeds - Nurix intends to use the net proceeds primarily for clinical development of drug candidates, including bexobrutideg (NX-5948) for chronic lymphocytic leukemia (CLL) and potential autoimmune indications [4]. - Additional uses include funding research and development to expand the pipeline, as well as for working capital and general corporate purposes [4]. Group 3: Management and Registration - J.P. Morgan Securities LLC, Jefferies LLC, and Stifel, Nicolaus & Company are acting as joint book-running managers for the offering [3]. - The offering is made under a shelf registration statement previously filed with the SEC, which was declared effective on June 11, 2024 [5].
Appili Therapeutics to Attend BARDA Innovation Symposium 2025
Globenewswire· 2025-10-22 11:20
Highlights Government-Funded Pipeline and Expanding Role of Public-Private Partnerships in Biodefense InnovationHALIFAX, Nova Scotia, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Appili Therapeutics Inc. (TSX: APLI; OTC Pink: APLIF) (“Appili” or the “Company”) today announced that it will attend the Biomedical Advanced Research and Development Authority (BARDA) Innovation Symposium on November 20, 2025, in Washington, D.C. The event brings together leaders from government, industry, and academia to advance the develop ...
Gilat to Report Third Quarter 2025 Results on Wednesday, November 12th
Globenewswire· 2025-10-22 11:18
Core Insights - Gilat Satellite Networks Ltd. will release its third quarter 2025 financial results on November 12, 2025 [1] - The conference call will feature CEO Adi Sfadia and CFO Gil Benyamini discussing the results and business achievements [2] Company Overview - Gilat Satellite Networks is a leading global provider of satellite-based broadband communications with over 35 years of experience [3] - The company develops deep technology solutions for satellite, ground, and new space connectivity, focusing on critical connectivity for commercial and defense applications [3] Product and Service Offerings - Gilat offers integrated solutions supporting multi-orbit constellations, Very High Throughput Satellites (VHTS), and Software-Defined Satellites (SDS) [4] - The product portfolio includes cloud-based platforms, high-performance satellite terminals, advanced antennas, Solid State Power Amplifiers (SSPA), and Block Upconverters (BUC) [4] Market Applications - Gilat's products support various applications including government and defense, in-flight connectivity, broadband access, cellular backhaul, enterprise, aerospace, broadcast, and critical infrastructure [5]
Galera Therapeutics Announces Acquisition of Dismutase Mimetics Portfolio by Toronto-based Biossil for up to $105 Million
Globenewswire· 2025-10-22 11:00
Galera has entered into an Asset Purchase Agreement with Toronto-based Biossil for Galera’s dismutase mimetics portfolio, including all avasopasem and rucosopasem formulations and indications. The agreement includes 1) an upfront payment of $3.5 million, 2) potential future regulatory milestones, commercial milestones, and contingent value rights of up to $105 million. Biossil assumes all further obligations to Blackstone Life Sciences under the 2018 Amended and Restated Purchase and Sale Agreement (the Ro ...
Old National Bancorp Reports Third Quarter 2025 Results
Globenewswire· 2025-10-22 11:00
Core Insights - Old National Bancorp reported a net income applicable to common shares of $178.5 million for Q3 2025, with a diluted EPS of $0.46. Adjusted figures show a net income of $231.3 million and an adjusted EPS of $0.59 [1][4]. Financial Performance - Net interest income on a fully taxable equivalent basis reached $582.6 million, with a net interest margin (NIM) of 3.64%, reflecting an increase of 11 basis points [2][11]. - Pre-provision net revenue (PPNR) was reported at $267.3 million, with an adjusted PPNR of $336.6 million, marking a 16% increase [2]. - Noninterest income totaled $130.5 million, with organic growth and record capital markets revenue contributing to this figure [2][11]. Expenses and Efficiency - Noninterest expenses were $445.7 million, including $69.3 million in merger-related charges. Adjusted noninterest expenses were $376.5 million [2][11]. - The efficiency ratio stood at 58.8%, while the adjusted efficiency ratio was 48.1%, indicating improved operational efficiency [2][11]. Deposits and Loans - Total deposits at the end of the period were $55.0 billion, reflecting a 4.8% annualized growth, with core deposits increasing by 5.8% [2][11]. - Total loans amounted to $48.0 billion, with a 0.6% annualized increase. Excluding loans acquired from Bremer, total loans grew by 3.1% [2][11]. Credit Quality - The provision for credit losses was $26.7 million, with net charge-offs of $30.0 million, representing 25 basis points of average loans [2][11]. - 30+ day delinquencies were at 0.18%, and nonaccrual loans accounted for 1.23% of total loans, indicating resilient credit quality [2][11]. Capital Position - Return on average tangible common equity (ROATCE) was reported at 15.9%, with an adjusted ROATCE of 20.1% [2]. - Preliminary regulatory Tier 1 common equity to risk-weighted assets was 11.02%, up 28 basis points [2][11].
Village Farms Introduces Industry-First, One-Way Aroma Valve in Cannabis Packaging
Globenewswire· 2025-10-22 11:00
Core Insights - Village Farms International, Inc. has launched an innovative one-way aroma valve in its Pure Sunfarms brand packaging, allowing consumers to smell the cannabis flower before purchase, marking a first in Canada [1][2][3] Company Overview - Village Farms is a large-scale, vertically-integrated supplier of plant-based Consumer Packaged Goods, leveraging decades of experience in Controlled Environment Agriculture [5] - The company operates one of the largest cannabis operations globally, with 2.2 million square feet of greenhouse production in Canada, and is recognized as a low-cost producer with high-quality products [6] Product Innovation - The one-way aroma valve is pressure-activated, enabling the release of the flower's scent when squeezed, while preventing air and contaminants from entering the package, enhancing the consumer experience [2][3] - This innovation follows the introduction of window packaging, furthering the mission to make cannabis shopping more accessible and informative [3][4] Market Expansion - Village Farms is targeting international cannabis opportunities, exporting medical cannabis to markets such as Germany, the UK, Israel, Australia, and New Zealand, and expanding its export business [7] - The company plans to enter the US THC market, utilizing its Texas-based greenhouse assets for future growth [8]
Atea Pharmaceuticals to Host Virtual HCV KOL Panel Event on November 13, 2025
Globenewswire· 2025-10-22 11:00
BOSTON, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (Atea or Company), a clinical-stage biopharmaceutical company engaged in the discovery and development of oral antiviral therapeutics for serious viral diseases, today announced that it will host a virtual key opinion leader (KOL) event on Thursday, November 13, 2025 at 10:00 AM ET to discuss a wide range of hepatitis C virus (HCV)-related topics including the current HCV patient population, the importance of early diagnosis ...
Marex Group plc to acquire European fixed income market maker Valcourt SA
Globenewswire· 2025-10-22 11:00
LONDON, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Marex Group plc (‘Marex’ or the ‘Group’; NASDAQ: MRX), the diversified global financial services platform, today announces that it has agreed to acquire Valcourt SA (“Valcourt”). Valcourt is a fixed income market maker based in Geneva, Switzerland, specialising in fixed income instruments such as high-yield, subordinated, emerging markets, private, illiquid, and sustainable debt. The acquisition will add 700 clients ranging from banks, independent wealth managers an ...
T1 Energy Announces Preliminary Results for Third Quarter 2025
Globenewswire· 2025-10-22 11:00
AUSTIN, Texas and NEW YORK, Oct. 22, 2025 (GLOBE NEWSWIRE) -- T1 Energy Inc. (NYSE: TE) (“T1,” “T1 Energy,” or the “Company”) has announced preliminary financial and operating results for the third quarter 2025. Preliminary Third Quarter 2025 Results Overview Total Net Sales/Modules Sales Volumes: T1 generated total net sales for the third quarter of $200 - $210 million on modules sales of approximately 725 MW.Maintaining 2025 EBITDA guidance range of $25 - $50 million. In Q4 2025, T1 expects a significant ...
Enthusiast Gaming Provides Update Regarding Annual General and Special Meeting of Shareholders
Globenewswire· 2025-10-22 11:00
Core Points - Enthusiast Gaming Holdings Inc. is providing an update regarding the impact of the ongoing Canadian Union of Postal Workers strike on the delivery of proxy-related materials for its upcoming annual general and special meeting of shareholders [1][3] - The meeting is scheduled to be held virtually on October 28, 2025, at 1:00 p.m. Toronto Time [2] - The company completed mailing proxy-related materials on October 15, 2025, but delivery prior to the meeting is not guaranteed due to the postal strike [3] - Shareholders are encouraged to access electronic copies of the meeting materials available on SEDAR+ or request them directly from the company [5] Meeting Details - The meeting will cover several key matters including the approval of consolidated financial statements for the year ended December 31, 2024, the election of directors, and the appointment of auditors for the ensuing year [6] - A resolution will also be considered regarding the issuance of common shares upon the exercise of warrants held by Beedie Investments Ltd. [6] Proxy Submission - To accommodate potential mailing delays, the company will accept properly executed proxies submitted after the original deadline, as long as they are received by 5:00 p.m. on October 27, 2025 [4] - Shareholders who have not received their materials by mail are advised to contact their intermediaries or access electronic versions [5]